Literature DB >> 9687556

Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response.

T Preston1, C Slater, D C McMillan, J S Falconer, A Shenkin, K C Fearon.   

Abstract

The unusual amino acid composition of acute phase proteins may be relevant to our understanding of the mechanism of tissue wasting in chronic inflammatory disease. During periods in which demand for amino acids outstrips dietary supply, skeletal muscle protein may be mobilized to meet this demand. An imbalance in the amino acid composition of these proteins may thus be detrimental to the body's nitrogen economy. To address this problem, we have measured the synthetic rate of fibrinogen (perhaps the major acute phase protein) and plasma amino acid profiles in a group of patients with adenocarcinoma of the pancreas and an ongoing inflammatory response (serum C-reactive protein >10 mg/L in the absence of any other obvious infective or inflammatory cause). These were also measured in a control group with no evidence of inflammation. Fibrinogen synthesis was measured after an overnight fast, using a flooding dose of 2H5-phenylalanine. The fractional rate of fibrinogen synthesis was significantly elevated in the cancer group compared with healthy controls [39.3 (20.0-49.9) and 21.9 (13.2-37.7) %/d, respectively; median (range), P < 0.05]. The absolute rate of fibrinogen synthesis was also elevated [84 (33-143) and 26 (15-43) mg/(kg.d), respectively; median (range), P < 0.01]. We calculated that, in cancer patients with anorexia-cachexia (i.e., documented ongoing weight loss in the absence of an obvious cause such as obstruction or malabsorption), aromatic amino acid supply (predominantly tryptophan) most limits fibrinogen synthesis from skeletal muscle reserves. Demand for the nonessential amino acids serine and glycine was elevated. Assuming that tryptophan is limiting, up to 2.6 g muscle protein ( approximately 12 g skeletal muscle tissue) may be wasted to synthesize 1 g fibrinogen. Interpretation of the observation that circulating free tryptophan concentrations were significantly reduced in the cancer patients will have to await flux measurements. The metabolic changes accompanying the inflammatory response suggest that down-regulation of this process may be beneficial.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9687556     DOI: 10.1093/jn/128.8.1355

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  29 in total

Review 1.  Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy.

Authors:  Thomas W Buford; Stephen D Anton; Andrew R Judge; Emanuele Marzetti; Stephanie E Wohlgemuth; Christy S Carter; Christiaan Leeuwenburgh; Marco Pahor; Todd M Manini
Journal:  Ageing Res Rev       Date:  2010-05-14       Impact factor: 10.895

Review 2.  Implications of preoperative hypoalbuminemia in colorectal surgery.

Authors:  Adam Truong; Mark H Hanna; Zhobin Moghadamyeghaneh; Michael J Stamos
Journal:  World J Gastrointest Surg       Date:  2016-05-27

Review 3.  STAT3 in the systemic inflammation of cancer cachexia.

Authors:  Teresa A Zimmers; Melissa L Fishel; Andrea Bonetto
Journal:  Semin Cell Dev Biol       Date:  2016-02-06       Impact factor: 7.727

4.  Systemic zinc redistribution and dyshomeostasis in cancer cachexia.

Authors:  Pontus M A Siren; Matti J Siren
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-10-26       Impact factor: 12.910

5.  Distinct glycoforms of human alpha1-acid glycoprotein have comparable synthesis rates: a [13C]valine-labelling study in healthy humans.

Authors:  Dennis C W Poland; Willem Kulik; Willem van Dijk; Marcella M Hallemeesch; Cornelis Jakobs; Kees de Meer
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

6.  Fibrinogen - a possible extracellular target for inositol phosphates.

Authors:  Thomas Grint; Andrew M Riley; Stephen J Mills; Barry V L Potter; Stephen T Safrany
Journal:  Messenger (Los Angel)       Date:  2012-12-01

7.  Associations between a patient-reported outcome (PRO) measure of sarcopenia and falls, functional status, and physical performance in older patients with cancer.

Authors:  Jennifer S Gewandter; William Dale; Allison Magnuson; Chintan Pandya; Charles E Heckler; Tatyana Lemelman; Breton Roussel; Rafa Ifthikhar; James Dolan; Katia Noyes; Supriya G Mohile
Journal:  J Geriatr Oncol       Date:  2015-09-11       Impact factor: 3.599

Review 8.  Understanding cachexia in the context of metastatic progression.

Authors:  Anup K Biswas; Swarnali Acharyya
Journal:  Nat Rev Cancer       Date:  2020-03-31       Impact factor: 60.716

Review 9.  Nutritional support in patients with oesophageal cancer.

Authors:  Federico Bozzetti
Journal:  Support Care Cancer       Date:  2009-06-24       Impact factor: 3.603

10.  The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer.

Authors:  D A C Deans; B H Tan; S J Wigmore; J A Ross; A C de Beaux; S Paterson-Brown; K C H Fearon
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.